Home' Australian Pharmacist : Australian Pharmacist March 2015 Contents Australian Pharmacist March 2015 I © Pharmaceutical Society of Australia Ltd.
Items in the Product news section are prepared from information provided by the companies named in each
item. They are included for the information of PSA members. It is up to the individual member to use their
professional judgment to decide on the merit or otherwise of each product mentioned. PSA neither endorses
nor confirms claims made in the items. (Where provided by the company references citing evidence are
included with the items.)
Australian Pharmacist is a professional journal. It will carry only advertising which is likely to be of interest to all
pharmacists and which does not reflect unfavourably directly or by implication on the pharmacy profession or
the professional practice of pharmacy. Advertising which does not comply with this policy will be refused. It is
the responsibility of the advertisers to comply with the relevant Commonwealth and State law. Advertising does
not constitute an endorsement by PSA of the claims, products or services.
Read in greater detail more regularly than any other pharmacy title –
such constant behaviour means you can count on our readers to open
any issue and be seen!
» Greatest number of recipients opening and reading (82%)
» Greatest number of readers reading every issue (48%)
Engage with almost 18,800 PSA members every month (15,500
pharmacists in print and 16,000 in digital form).
» Australian Pharmacist is read by 65% of community pharmacists
It has an extremely strong CPD program followed by more than 10,000
pharmacists – a typical monthly article receives 3000 plus assessments,
with highs over 4000!
» Greatest average proportion read (73%)
» Circulation 14,872 cab March 2013
TO ADVERTISE in the best-read pages in pharmacy media and give your campaign real
impact, and greater recognition, contact Tremain Media.
Ph: 02 9988 4689
Ph: 02 9547 3001
Ph: 02 9871 5520
*Competitive Advantage Research August 2012 – 632 practicing community pharmacists
Answers for crossword on page 59.
Across: 1. Chilled, 4. Abet, 7. Ah, 8. Ribbon,
10. Pa, 11. Odour, 12. Trot, 13. Weeping, 16.
Ma, 17. Axe, 18. Wound, 19. Keratin, 21. Be,
22. Black, 24. Un, 25. Hydrogels, 27. Larvae,
29. Alginates, 34. Zinc, 35. Am, 37. Silicone,
40. Burns, 41. No, 42. Narrow.
Down: 1. Charcoal, 2. Isotonic, 3. Exudate,
4. Ab, 5. Boring, 6. En, 7. Apt, 9. Bleeding,
13. Wa, 14. Ex, 15. Green, 20. Red, 21. Bus,
23. Air, 25. Healing, 26. Lie, 28. Vacuum, 30.
Gas, 31. Nylon, 32. Tic, 33. San, 34. Zone,
36. Meow, 38. In, 39. Oar.
Coloured contact lenses
ColourVue coloured contact lenses
are Therapeutic Goods Administration
approved contact lenses which use a
patented hydrogel material featuring high
oxygen permeability and water content.
The tri-layer sandwich technology used by
ColourVue protects the eyes from irritation
and preserves the colour of the lens.
Chosen for the most dynamic
designs and widest range of colours
in the market, a growing number of
pharmacies in Australia are successfully
offering non-prescription ColourVue
contact lenses. ABK Vision stocks over
100 designs, from novelty costume
lenses (perfect for photo-shoots,
dress-up parties and Halloween) to a
wide variety of beauty enhancing lenses
for every day.
ColourVue lenses are available as re-
usables (up to three month) or as daily
disposables. In-store marketing support,
like counter stands, sample displays,
brochures, pull up banners and posters
are also available. For more information
visit: www.colourvue.net.au or call ABK
Vision on 1800 633 657
MS Health has launched the MS-2 Step
(mifepristone, misoprostol) composite
pack with a new indication of up to
63 days gestation for the purposes of
early medical termination of pregnancy.
MS-2 Step replaces Mifepristone
Linepharma and GyMiso single packs
indicated for early medical termination
of pregnancy up to 49 days gestation.
MS-2 Step will be available on the PBS.
The Mifepristone Linepharma single
pack will continue to be marketed by
MS Health for females of childbearing
age for preparation for the action of
registered prostaglandin analogues
that are indicated for the termination
of pregnancy for medical reasons
beyond the first trimester.
to the availability and PBS listing of
the Mifepristone Linepharma and
GyMiso single packs will occur with the
introduction of the MS-2 Step composite
pack. GyMiso will also no longer be
marketed as a single pack by MS Health.
The new indication of the MS-2 Step
composite pack gives women an
additional 14 days in which to choose an
early medical termination of pregnancy
before having to undertake a surgical
1. Approved Product Information MS-2 Step (mifepristone,
Links Archive Australian Pharmacist February 2015 Australian Pharmacist April 2015 Navigation Previous Page Next Page